Science Advances · 4 September 2026 · From issue 33
Lenacapavir allosterically remodels the HIV-1 capsid
In lab studies, a drug breaks the HIV shell in two steps, starting at its curviest points.
Nayara F. B. dos Santos, Jacob A. Lewis et al.
A drug called lenacapavir treats and prevents HIV infection by breaking apart the virus's protective shell. This shell is shaped like a cone made of many small protein pieces. The drug changes how these pieces stick together. It cracks the sharpest, most curved parts of the cone first, then splits the rest of the shell apart.
Integrity screen: passed (3 checks) Checked 8 September 2026. Read the source
The plain-language reading of this paper is in the full issue, for subscribers.
Read the full issue